| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OSRH | Common Stock | Other | $0 | +43K | +2.15% | $0.00 | 2.04M | Feb 14, 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents 430,000 private placement rights which were converted into 43,000 shares of common stock at the closing of a business combination between Bellevue Life Science Acquisition Corp. and OSR Holdings Co., Ltd. |
| F2 | Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC, the sponsor of the Issuer (the "Sponsor") whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor. |